Japanese Lung Cancer Research Trends and Performance in Science Citation Index
Internal MedicinePublished 1 January 2010Open access
Yuh‐Shan Ho, Hiroaki Satoh, Shih-Yuan Lin
Citations166
SJR quartileQ3
SJR score0.33
SNIP0.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Keyword analysis indicated that there has been a strategy to connect molecular biology with clinical practice in Japan and highlights the topics in lung cancer research that are becoming popular in Japan.
Abstract
Finally, this study highlights the topics in lung cancer research that are becoming popular in Japan.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Science<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
9,415 Citations2004J. Guillermo Paez, Pasi A. Jänne +15 more
Results suggest that EGFR mutations may predict sensitivity to gefitinib, and treatment with the EGFR kinase inhibitor gefitsinib causes tumor regression in some patients with NSCLC, more frequently in Japan.
CHEST JournalRevisions in the International System for Staging Lung Cancer
4,598 Citations1997Clifton F. Mountain
Analysis of a collected database representing all clinical, surgical-pathologic, and follow-up information for 5,319 patients treated for primary lung cancer confirmed the validity of the TNM and stage grouping classification schema.
Journal of Clinical OncologyMulti-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2,887 Citations2003Masahiro Fukuoka, Seiji Yano +18 more
Gefitinib showed clinically meaningful antitumor activity and provided symptom relief as second- and third-line treatment in patients with pretreated advanced non-small-cell lung cancer.
BMJChemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
2,850 Citations1995Non-small Cell Lung Cancer Collaborative Group
The results of this meta-analysis suggest that chemotherapy may have a role in treating non-small cell lung cancer, and reached conventional levels of significance when used with radical radiotherapy and with supportive care.
JNCI Journal of the National Cancer InstituteClinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2,371 Citations2005Hisayuki Shigematsu, Lin Li +14 more
EGFR TK domain mutations are the first molecular change known to occur specifically in never smokers, and can lead to lung cancer pathogenesis.
Journal of Clinical OncologyPhase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
1,508 Citations1999Kiyoyuki Furuse, Masahiro Fukuoka +6 more
In selected patients with unresectable stage III NSCLC, the concurrent approach yields a significantly increased response rate and enhanced median survival duration when compared with the sequential approach.
New England Journal of MedicineA Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
1,324 Citations1992Jean‐Pierre Pignon, R. Arriagada +12 more
Thoracic radiotherapy moderately improves survival in patients with limited small-cell lung cancer who are treated with combination chemotherapy, and identification of the optimal combination of chemotherapy and radiotherapy will require further trials.
New England Journal of MedicineEffects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
1,285 Citations1992C. Schaake-Koning, Walter Van den Bogaert +14 more
Cisplatin, given daily in combination with the radiotherapy described here to patients with nonmetastatic but inoperable non-small-cell lung cancer, improved rates of survival and control of local disease at the price of substantial side effects.
PubMedInhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
1,036 Citations1999Jann N. Sarkaria, Ericka C. Busby +5 more
Caffeine inhibits the catalytic activity of both ATM and the related kinase, ATM and Rad3-related (ATR), at drug concentrations similar to those that induce radiosensitization, suggesting that both proteins are relevant targets for the development of novel anticancer agents.
PubMedReduced angiogenesis and tumor progression in gelatinase A-deficient mice.
878 Citations1998Takeshi Itoh, Masatoshi Tanioka +4 more
It is indicated that host-derived gelatinase A plays an important role in angiogenesis and tumor progression, suggesting the usefulness of gelatin enzyme A inhibitors for anticancer chemotherapy.
BMJNon-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan.
791 Citations1981Takeshi Hirayama
The results indicate the possible importance of passive or indirect smoking as one of the causal factors of lung cancer and appear to explain the long-standing riddle of why many women develop lung cancer although they themselves are non-smokers.
Journal of Clinical OncologyPhase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104
704 Citations2002Minoru Takada, Masahiro Fukuoka +10 more
This study strongly suggests that cisplatin plus etoposide and concurrent radiotherapy is more effective for the treatment of LS-SCLC than cisPlatin plus Etoposid and sequential radiotherapy.
Journal of Thoracic and Cardiovascular SurgeryPrognosis and survival in resected lung carcinoma based on the new international staging system
691 Citations1988Tsuguo Naruke, Tomoyuki Goya +2 more
In both the clinical stage and the postoperative stage, there were significant prognostic differences between stage I and stage II, stage II andStage IIIA, andstage IIIA and stage IIIB, but there was no significant difference in 5-year survival rates between stageIIIB and stage IV.
ScientometricsGlobal stem cell research trend: Bibliometric analysis as a tool for mapping of trends from 1991 to 2006
309 Citations2009Lingli Li, Guohua Ding +3 more
It can be concluded that application of stem cell transplantation technology to human disease therapy, especially research related on “embryonic stem cell” and “mesenchymal stemcell” is the orientation of all the stem cell research in the 21st century.
ScientometricsAssessment of world aerosol research trends by bibliometric analysis
201 Citations2008Shaodong Xie, Jing Zhang +1 more
A bibliometric approach to quantitatively assessing current research trends on atmospheric aerosol, using the related literature in the Science Citation Index (SCI) database from 1991 to 2006 was explored.
ScientometricsA bibliometric and citation analysis of stroke-related research in Taiwan
164 Citations2007Kun‐Yang Chuang, Yali Huang +1 more
To improve the quality and efficiency of stroke research, continuity in research focuses needs to be maintained, and thus funding should be allocated on a long-term basis to institutes with a proven record of success.
Bibliometric Analysis of Adsorption Technology in Environmental Science
101 Citations2007Yuh‐Shan Ho
The results reveal that yearly production of adsorption-related scientific articles increased steadily over the investigation period, and Environmental Science & Technology, which has one of the highest impact factors in the field of environmental science journals, published 7 of the 10 most frequently cited articles.
ScientometricsUse of citation per publication as an indicator to evaluate pentachlorophenol research
43 Citations2008Huang Yi, Xiaolan Ao +1 more
A bibliometric analysis of all pentachlorophenolrelated publications in the SCI found the mean value of citation per publication of collaborative papers was higher than that of single country publications.
Japanese Journal of Clinical OncologyJapan Clinical Oncology Group (JCOG)
42 Citations1998M Shimoyama, Haruhiko Fukuda +2 more
The Japan Clinical Oncology Group (JCOG) is a cooperative oncology group with the aims of conducting, developing, coordinating and stimulating clinical research in Japan on the treatment of cancer and related problems.
PubMedDevelopments in the treatment of non-small cell lung cancer.
34 Citations2007Ioannis Gkiozos, Andriani Charpidou +1 more
An abundant amount of research is still required in the field of lung cancer therapy with well-designed clinical trials and appropriate patient selection, there is a clear need for improvement in the current standard of care.
DMW - Deutsche Medizinische WochenschriftRadikaloperation eines primären Lungenkarzinoms<sup>1</sup>)
3 Citations1913Jerome Rotter
The Tohoku Journal of Experimental MedicineUnusual Intraluminal Processes of Capillaries in a Case of Undifferentiated Lung Cancer
2 Citations1973ENG SEND ANG, T Neyazaki +3 more
Extremely long villous processes projected from endothelium toward capillary canal was observed in the blood vessels of very malignant pulmonary carcinoma.